Published April 23, 2021 | Version v1
Dataset Open

Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute Phase Non-Hospitalized COVID-19 Patients: Implications for Assessment of Post Acute COVID-19 Syndrome

Creators

  • 1. Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5, Robin Warren Drive, Perth, Western Australia, 6150 Australia
  • 2. Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, 5 Robin Warren Drive, Perth, Western Australia, 6150 Australia
  • 3. Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, U.K.
  • 4. Bruker Pty. Ltd, Preston, Australia, Victoria 3072, Australia
  • 5. State Adult Burn Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia
  • 6. Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, U.K.
  • 7. Medical School, University of Western Australia, and Department of Surgery, Fiona Stanley Hospital, Harry Perkins Building, Murdoch, Perth, Western Australia 6150, Australia
  • 8. Medical School, University of Western Australia, Harry Perkins Building, Murdoch, Perth, Western Australia 6150, Australia, and Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Murdoch, Perth, Western Australia 6150, Australia
  • 9. Singapore National NeuroScience Centre, Singapore Mandalay Road, 308232, Singapore
  • 10. Bruker Biospin GmbH, Ettlingen 76275, Germany

Description

We present a multivariate metabotyping approach to assess the functional recovery of non-hospitalized COVID-19 patients and the possible biochemical sequelae of “Post Acute COVID-19 Syndrome”, colloquially known as long-COVID. Blood samples were taken from patients ca. 3 months post-acute COVID-19 infection who were also assessed symptomatically at 6 months. Some 57% of patients had one or more persistent symptoms including respiratory-related symptoms cough, dyspnoea and rhinorrhea or other non-respiratory symptoms including chronic fatigue, anosmia, myalgia, joint pain. Plasma samples were quantitatively analysed for lipoproteins, glycoproteins, amino acids, biogenic amines and tryptophan pathway intermediates using NMR spectroscopy and mass spectrometry. Metabolic data for the follow-up patients (n=27) were compared with controls (n=41) and hospitalized SARS CoV-2 positive patients (n=18, with multiple time-points). Univariate and multivariate statistics revealed variable patterns of functional recovery with many patients exhibiting residual COVID-19 biomarker signatures. Several parameters were persistently pathophysiological, e.g. elevated taurine (p= 3.6 x 10-3 vs controls) and reduced glutamine/glutamate ratio (p = 6.95 x 10-8 vs controls) indicative of possible liver and muscle damage and a high energy demand linked to more generalized tissue repair or immune function. Some parameters showed near complete normalization, e.g. the plasma apolipoprotein B100/A1 ratio was similar to healthy controls, but significantly lower (p= 4.2 x 10-3) than acute COVID-19 patients, reflecting partial phenoreversion towards the healthy metabolic state. Plasma neopterin was normalized in all follow-up patients indicative of reduction in adaptive immune activity that has been previously detected in active SARS-CoV-2 infection. Other systemic inflammatory biomarkers such as GlycA and the kynurenine/tryptophan ratio remained elevated in some, but not all, patients. Correlation analysis, PCA and OPLS-DA showed that the follow-up patients were as a group metabolically distinct from controls and partially co-mapping with the acute phase patients. Significant systematic metabolic differences between asymptomatic and symptomatic follow-up patients were also observed for multiple metabolites. The overall metabolic variance of the symptomatic patients was significantly greater than non-symptomatic patients for multiple parameters (Chi-squared P=0.014). Thus, asymptomatic follow-up patients including those with “Post-COVID Syndrome” display a spectrum of multiple persistent biochemical pathophysiology suggesting that the metabolic phenotyping approach may be deployed for multi-system functional assessment of individual post-COVID-19 patients.

Files

sampleDescriptionList.txt

Files (3.0 GB)

Name Size Download all
md5:7e483c2dec217b2aaec45f361fabdfc2
977.7 kB Download
md5:bc6b10b71e2052ef76ee7882ba13676d
977.7 kB Download
md5:ffe586a7e47ae11fd368378da2d1abf5
977.9 kB Download
md5:8628e4e068707711422a99174e2caf9f
977.6 kB Download
md5:e6fdbc3fc1ff36f3cec245f8292b6964
977.5 kB Download
md5:52a1dbe788f7fe76e1c44902af3fcc82
977.7 kB Download
md5:f200c7fc9e978acc831f53ac46bc75c0
977.7 kB Download
md5:c7366ec596ec790e13df2c78e7f14d56
977.5 kB Download
md5:ab81657da7b6550ffe66100da68d4f30
321.6 MB Download
md5:5dc8c5c47d6a15fb4b42d33fa4fb0b14
977.9 kB Download
md5:3c1c23a28da1edf41445879df2a09cfc
977.7 kB Download
md5:82181e26c890aaa465f3b32c07fd0e15
977.7 kB Download
md5:227dcc7d0490fe3c5887f1383eaaea1e
978.3 kB Download
md5:628a0c5ff2ce9f34be5699db0442b6fe
329.3 MB Download
md5:666088d3803585f266d96c2eb6427be9
977.5 kB Download
md5:b6e42e0a82eb833657a668ccb54070b4
320.7 MB Download
md5:028d2ad0d6727158c23482584e18c657
977.7 kB Download
md5:e9ac4fb346de27f4d5caefdf805b5ce3
324.3 MB Download
md5:abe5a39e11866bdffdf5faf7872c1e44
977.9 kB Download
md5:42ada193266fbb24e48e8c5371cd7e35
329.4 MB Download
md5:a8ce106fed6e2485a59b80fffd238b60
977.7 kB Download
md5:50a4d53c22b606cad4c22efd8d332a23
977.9 kB Download
md5:d2babc69894bf9aabe77c65e60872a5b
977.7 kB Download
md5:4e26d91fb272ee2e0eb7e35b427076d2
330.6 MB Download
md5:920da4b5504c35d9cff96c20a553539e
977.7 kB Download
md5:4af420e90ac4007385a5ad26d415af64
326.7 MB Download
md5:d8ba456aaa906a18fb6ff11f8267533d
977.7 kB Download
md5:899d38a6348fca13c3b7cbd2c59d70f3
977.9 kB Download
md5:f1ac72940b6f1ad693dfb1615a4c1df7
324.1 MB Download
md5:62e05ce99ef2a12b7ac55631863d4648
977.8 kB Download
md5:e716101194429e621701415f22d1a103
977.7 kB Download
md5:ef68f4dbceeb366c7063661a0e0930c8
326.1 MB Download
md5:35b09224ce791c6e9c8fc10be069cc5f
1.4 kB Download
md5:5f2c027c3d347bd2eeb9a4e92ffbb16c
3.8 kB Preview Download
md5:80e27e4935ddb6da62418d17491316c2
845.6 kB Preview Download
md5:405772a2cf02467374b3e38d9e266c22
538.1 kB Preview Download
md5:d073b74c83db596d76298e4b684a34f1
28.9 kB Preview Download
md5:b9f1175124ca2a1e6eb796eb63915614
10.1 kB Preview Download